{"id":777719,"date":"2026-07-03T13:44:08","date_gmt":"2026-07-03T13:44:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/777719\/"},"modified":"2026-07-03T13:44:08","modified_gmt":"2026-07-03T13:44:08","slug":"study-suggests-ocular-history-may-raise-risk-for-recurrent-shingles","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/777719\/","title":{"rendered":"Study suggests ocular history may raise risk for recurrent shingles"},"content":{"rendered":"<p>New clinical findings have found patients with prior herpes zoster ophthalmicus (HZO) were more likely to experience a recurrence in the first 8 weeks after receiving a shingles vaccine, compared with the 8 weeks that followed.<\/p>\n<p>The <a href=\"https:\/\/eppro02.ativ.me\/web\/page.php?page=IntHtml&amp;project=ARVO26&amp;id=4492599\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">data was presented<\/a> during last month\u2019s Association for Research in Vision and Ophthalmology (<a href=\"https:\/\/eppro02.ativ.me\/web\/page.php?page=IntHtml&amp;project=ARVO26&amp;id=4492599\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">ARVO)<\/a> annual meeting.<\/p>\n<p>Give me some background first.<\/p>\n<p>Some context: HZO is <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557779\/\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">reactivation of the varicella zoster virus<\/a> along the ophthalmic branch of the trigeminal nerve. It can cause a range of ocular complications, from keratitis and uveitis to optic neuropathy and permanent vision loss.<\/p>\n<p>A few facts to know:<\/p>\n<p>And to prevent this?<\/p>\n<p>The live zoster vaccine has been replaced by the recombinant zoster vaccine (Shingrix), which the <a href=\"https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/index.html\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">CDC&#8217;s Advisory Committee on Immunization Practices recommends<\/a> as the preferred option for immunocompetent adults aged 50 and older.<\/p>\n<p>But here&#8217;s the issue: Few existing studies have examined recurrence risk in patients with pre-existing HZO who go on to receive a shingles vaccine\u2014leaving an open clinical concern about whether vaccination might trigger reactivation in eyes that have already been affected.<\/p>\n<p>Now, talk about the study.<\/p>\n<p>Researchers at Kaiser Permanente Northern California ran a retrospective cohort study using their integrated health system records.<\/p>\n<p>The question: Is there an increased risk of recurrent HZO in the period immediately following shingles vaccination?<\/p>\n<p>The setup: Researchers used a self-controlled risk interval (SCRI) analysis, where each patient served as their own control.<\/p>\n<p>The risk interval was defined as days 1 to 56 after a dose of the shingles vaccine, compared against a self-controlled interval of days 57 to 112 after the same dose.Who was included in the study?<\/p>\n<p>The cohort included 10,018 patients aged 50 and older with an incident HZO diagnosis between 2010 and 2023.<\/p>\n<p>To make the cut, patients needed to have:<\/p>\n<p>An incident HZO diagnosis on recordSubsequently received either the live zoster vaccine, the recombinant zoster vaccine, or both<\/p>\n<p>Of the full cohort, 2,900 went on to receive shingles vaccination during the study window.<\/p>\n<p>Findings?<\/p>\n<p>Across the 112 days following any shingles vaccination, 38 cases of recurrent HZO were identified.<\/p>\n<p>The kicker: Of those 38 recurrences, 34 (89%) had pre-existing ocular involvement before vaccination, compared with 1,193 (42%) of the patients who did not recur (p&lt;0.001).<\/p>\n<p>Time from incident HZO to first vaccination also differed between the groups, with a median of<\/p>\n<p>309 days (range: 185 to 625) in the recurrence group (p&lt;0.001)991 days (range: 451 to 1,900) in the non-recurrence group (p&lt;0.001)Tell me more.<\/p>\n<p>In the SCRI analysis, the incidence rate of HZO recurrence was higher during the days 1 to 56 risk interval than during the days 57 to 112 control interval, with an incidence rate ratio (IRR) of 2.05 (p=0.048).<\/p>\n<p>Worth noting: Recurrence in the first 8 weeks after vaccination ran at roughly twice the rate of the subsequent 8 weeks, though the overall absolute incidence remained low.<\/p>\n<p>Limitations?<\/p>\n<p>As this was an abstract presentation, the full peer-reviewed methods and additional sensitivity analyses were not made available.<\/p>\n<p>Among the other considerations:<\/p>\n<p>The study population was drawn from a single integrated health system, which limited how broadly the absolute rates generalizeLive zoster and recombinant zoster vaccine doses were combined in the primary analysis\u2014the abstract did not break out vaccine-specific riskThe study\u2019s self-controlled designExpert opinion?<\/p>\n<p>The authors concluded that the findings support vigilance around the timing of shingles vaccination in patients with pre-existing HZO, particularly those vaccinated soon after their initial diagnosis.<\/p>\n<p>Anything else?<\/p>\n<p>One finding that stands out: The recurrence group was vaccinated about two and a half times sooner after their initial HZO episode than the non-recurrence group.<\/p>\n<p>That timing gap, paired with the 89% rate of pre-existing ocular involvement, points to a window where vaccination may overlap with still-active disease.<\/p>\n<p>Why that matters: The <a href=\"https:\/\/www.cdc.gov\/shingles\/hcp\/vaccine-considerations\/index.html\" class=\"text-primary text-decoration-underline\" rel=\"nofollow noopener\" target=\"_blank\">ACIP currently recommends an 8-week interval<\/a> between Zostavax and a Shingrix dose, but there is no equivalent guidance on how long to wait after an incident HZO episode before vaccinating.<\/p>\n<p>The findings here raise the question of whether such an interval should be considered.<\/p>\n<p>Take home.<\/p>\n<p>Clinicians may want to take a closer look at vaccination timing in this population and counsel patients on what symptoms to watch for in the weeks immediately following a dose.<\/p>\n","protected":false},"excerpt":{"rendered":"New clinical findings have found patients with prior herpes zoster ophthalmicus (HZO) were more likely to experience a&hellip;\n","protected":false},"author":2,"featured_media":777720,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[49,48,84],"class_list":["post-777719","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-ca","tag-canada","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/777719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=777719"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/777719\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/777720"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=777719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=777719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=777719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}